Hayward, CA, United States of America

Fernando Corrêa

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Fernando Corrêa

Introduction

Fernando Corrêa is an accomplished inventor based in Hayward, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on addressing critical health issues through innovative solutions.

Latest Patents

One of Fernando's latest patents is related to IL-6 antibodies and fusion constructs and conjugates thereof. This invention provides antagonizing antibodies that bind to IL-6, along with fusion proteins that incorporate VEGF Trap. These anti-IL-6 antibodies can be utilized therapeutically, either alone or in combination with other treatments, to combat various diseases. Another notable patent involves complement factor D antagonist antibodies and conjugates thereof. This invention offers antibodies that bind to complement factor D (CFD) and outlines methods for their therapeutic use, particularly in treating age-related macular degeneration and other related conditions.

Career Highlights

Fernando Corrêa is currently associated with Kodiak Sciences Inc., where he continues to push the boundaries of medical innovation. His work is instrumental in developing therapies that can significantly improve patient outcomes.

Collaborations

Fernando collaborates with esteemed colleagues such as Daniel Victor Perlroth and Hong Liang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Fernando Corrêa's contributions to biotechnology through his patents and collaborative efforts highlight his commitment to advancing medical science. His work in developing therapeutic antibodies is paving the way for new treatments that can address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…